Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Breast Neoplasms 51Neoplasms 34Colorectal Neoplasms 23Lung Neoplasms 17Prostatic Neoplasms 16Melanoma 15Neoplastic Cells, Circulating 13Pancreatic Neoplasms 11Multiple Myeloma 11Uterine Cervical Neoplasms 10Ovarian Neoplasms 10Carcinoma, Non-Small-Cell Lung 8Papillomavirus Infections 7Neoplasm Metastasis 7Leukemia, Myeloid, Acute 7Colonic Neoplasms 7Lymphoma, Follicular 6Lymphoma 6Hematologic Neoplasms 6Uveal Melanoma 5Sarcoma 5Head and Neck Neoplasms 5Glioma 5Uterine Cervical Dysplasia 4Urinary Bladder Neoplasms 4Rectal Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Glioblastoma 4Disease 4COVID-19 4

Interventions

Cyclophosphamide 20fludarabine phosphate 19Peripheral Blood Stem Cell Transplantation 18Whole-Body Irradiation 15Cyclosporine 12Mycophenolic Acid 11Etoposide 9Busulfan 9Prednisone 8Vincristine 7Tacrolimus 7Filgrastim 7Carboplatin 7Bortezomib 7Antilymphocyte Serum 7Methotrexate 6Everolimus 6Doxorubicin 6Vorinostat 5Rituximab 5Gemcitabine 5Therapeutics 4Radiotherapy 4Panobinostat 4Paclitaxel 4Melphalan 4Lenalidomide 4Gene Expression Profiling 4Methylprednisolone 3MLN 8237 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Immunoblastic Lymphadenopathy × Blood Specimen Collection × Clear all
NCT00569309 2018-03-12

Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma

Ohio State University Comprehensive Cancer Center

Phase NA Completed
30 enrolled 8 charts
LymphoidPlasma cell

Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Follicular, Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Mantle-Cell, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡